Markets

‘We are going to have lung cancer patients living longer and better’: A new kind of cancer treatment is about to change how we treat the disease

New cancer treatments that harness the body’s immune system are ready to go mainstream. In data presented Monday at the American Association of Cancer Research’s annual meeting, cancer-drug makers found that immunotherapy in combination with other drugs did a better job of treating lung cancer than chemotherapy alone. A combination […]
‘We are going to have lung cancer patients living longer and better’: A new kind of cancer treatment is about to change how we treat the disease
Markets

A cancer drugmaker just failed a key trial and its stock is crashing

Cancer drugmaker Incyte said Friday that a key trial combining its cancer immunotherapy drug with a blockbuster drug from Merck failed in a late-stage trial. Incyte’s stock was down as much as 22% before markets opened on Friday morning, while Merck’s was down a little more than 1%. Cancer immunotherapy […]
A cancer drugmaker just failed a key trial and its stock is crashing
Next Page »